IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BUCELLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.162
NA - Nord America 892
AS - Asia 402
SA - Sud America 34
OC - Oceania 12
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 858
DE - Germania 387
GB - Regno Unito 256
IT - Italia 232
CN - Cina 205
SE - Svezia 93
IN - India 60
IE - Irlanda 45
JP - Giappone 39
CA - Canada 32
FR - Francia 25
ES - Italia 18
CH - Svizzera 17
ID - Indonesia 12
TW - Taiwan 12
VN - Vietnam 12
NL - Olanda 11
TR - Turchia 11
BE - Belgio 10
DK - Danimarca 10
KR - Corea 10
PH - Filippine 10
UA - Ucraina 10
HK - Hong Kong 9
AU - Australia 8
BR - Brasile 8
CO - Colombia 8
SG - Singapore 7
AT - Austria 6
EC - Ecuador 6
FI - Finlandia 6
TH - Thailandia 6
AR - Argentina 5
PT - Portogallo 5
RU - Federazione Russa 5
GR - Grecia 4
NZ - Nuova Zelanda 4
UZ - Uzbekistan 4
CL - Cile 3
PL - Polonia 3
SC - Seychelles 3
AX - Isole di terra 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
LB - Libano 2
MX - Messico 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 2.512
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 258
Southend 222
Chandler 117
Milan 102
Fairfield 89
Hanover 75
Ashburn 49
Princeton 46
Wilmington 46
Dublin 43
Woodbridge 42
New York 41
Ann Arbor 40
Seattle 34
Houston 28
Toronto 26
Cambridge 25
Phoenix 25
Beijing 23
Dearborn 18
Tokyo 16
Des Moines 15
Redwood City 15
Nanjing 14
Bengaluru 13
Berlin 13
Hangzhou 10
Shanghai 10
Brussels 9
Guangzhou 9
Jinan 9
Rome 9
Shenyang 9
Hong Kong 8
Mumbai 8
Stockholm 7
Zhengzhou 7
Boardman 6
Changsha 6
Delhi 6
London 6
San Diego 6
Ugong Norte 6
Como 5
Falls Church 5
Fremont 5
Grafing 5
Madrid 5
Santiago de Cali 5
Taipei 5
Vienna 5
Örebro 5
Andover 4
Athens 4
Bangkok 4
Birmingham 4
Bühl 4
Chicago 4
Dijon 4
Dong Ket 4
Hebei 4
Istanbul 4
Meguro-ku 4
Nanchang 4
Naples 4
Ningbo 4
São Paulo 4
Tianjin 4
Torino 4
Turin 4
Amsterdam 3
Chiswick 3
Dallas 3
Fuzhou 3
Guayaquil 3
Hanoi 3
Helsinki 3
Honolulu 3
Lanzhou 3
Los Angeles 3
Mahé 3
Medellín 3
Mountain View 3
Norwalk 3
Overland Park 3
Quito 3
Seoul 3
Silver Spring 3
Singapore 3
St. Petersburg 3
Taizhou 3
Tampa 3
The Dalles 3
Valencia 3
Vancouver 3
Vitoria de Santo Antao 3
Yangzhou 3
Yogyakarta 3
Adelaide 2
Amersfoort 2
Totale 1.771
Salva come PNG Salva come JPEG
Nome #
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 393
Prognostic significance of a comprehensive histologic evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients. 204
UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia 203
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 169
Anagrelide and Mutational Status in Essential Thrombocythemia 143
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach 128
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series 124
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 122
An unusual type of myeloid sarcoma localization following myelofibrosis : a case report and literature review 120
Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre 116
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 114
Imatinib and ruxolitinib association : first experience in two patients 108
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series 83
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study 83
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality 77
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients : A Safe and Effective Option 65
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 64
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients : a real clinical problem? 64
Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia 59
New perspectives on polycythemia vera : from diagnosis to therapy 52
Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy : Report of a Case 45
Comprehensive Molecular Analyses in a Case of Masked Philadelphia Chronic Myeloid Leukemia 42
Osteolytic lesions in primary myelofibrosis and effect of ruxolitinib therapy : Report of a case and literature review 40
Management of Myelofibrosis : from Diagnosis to New Target Therapies 24
Totale 2.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201942 0 0 0 0 0 0 0 0 0 0 30 12
2019/2020290 18 5 8 24 15 26 38 24 40 50 17 25
2020/2021307 41 25 17 10 28 21 20 49 25 37 11 23
2021/2022628 40 89 91 49 36 25 41 44 69 35 27 82
2022/2023584 78 47 58 39 55 102 13 49 69 15 47 12
2023/2024571 39 30 26 36 91 28 110 83 43 75 10 0
Totale 2.642